By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
IndebtaIndebta
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
IndebtaIndebta
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
Indebta > News > Robert Kennedy beats back anti-vax label in testy US Senate hearing
News

Robert Kennedy beats back anti-vax label in testy US Senate hearing

News Room
Last updated: 2025/01/29 at 1:57 PM
By News Room
Share
4 Min Read
SHARE

Unlock the White House Watch newsletter for free

Your guide to what the 2024 US election means for Washington and the world

Robert F Kennedy Jr, President Donald Trump’s pick to be the country’s top health official, appeared unscathed after a grilling by US senators on Wednesday, as he sought to quell criticisms from both sides of the aisle over his record on vaccines and abortion.

In a sometimes heated Senate finance committee hearing, Democratic senators blasted Kennedy for his history of promoting vaccine conspiracy theories, pointing to his role in sowing doubts about measles, polio and Covid-19 shots, and for his involvement in anti-vaccine lawsuits.

Kennedy also sought to allay concerns from some anti-abortion Republican senators over his shifting stance on the procedure. On four occasions, Kennedy stressed that he agreed with Trump that “every abortion is a tragedy”, saying he would defer to the president’s policies on abortion pill mifepristone.

Kennedy’s reception at the three-hour-long confirmation hearing split along party lines, suggesting the panel is likely to back his appointment as Health and Human Services secretary, which would put him in control of a sprawling department with a $1.8tn budget. He will face questions from another Senate panel on Thursday.

In his opening remarks — which were briefly interrupted by a protester shouting “he lies” — Kennedy stressed that he was “not anti-vaccine or anti-industry”, but “pro-safety”. Kennedy noted that all his children were vaccinated, adding that he supported both the polio and measles vaccines. “I believe that vaccines play a critical role in healthcare,” he said.

Democratic Senator Ron Wyden said Kennedy had “embraced conspiracy theories, quacks, charlatans”, while his colleague Elizabeth Warren said “kids might die” because of Kennedy’s anti-vaccine stance while he “can keep cashing in” from his role in vaccine safety lawsuits.

Republicans James Lankford and Thom Tillis, both viewed as possible opponents to Kennedy’s confirmation, took a more conciliatory approach. Kennedy assured Lankford that he would back the president’s policies on abortion. Tillis said he expected the vote to split along party lines: “Some of these nominations are going to be shirts and skins.”

Kennedy said his “Make America Healthy Again” campaign would solve chronic disease in the US, which he claimed was costing the country $4.3tn a year.

Kennedy also said he had been labelled a “conspiracy theorist” to prevent him from “asking difficult questions of powerful interests”.

Kennedy also sought to downplay Republican concerns over his plan to shake up the food industry. “I don’t want to take food away from anybody,” he said. “If you like a cheeseburger — a McDonald’s cheeseburger and a Diet Coke like my boss — you should be able to get them.”

Kennedy was grilled by Republican Senator Bill Cassidy, another crucial vote in getting him confirmed, over his plans to reform the state-backed Medicare and Medicaid health insurance programmes. “I don’t have a broad proposal for dismantling the programme,” he said.

Read the full article here

News Room January 29, 2025 January 29, 2025
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
How Black-ish Creator Kenya Barris and REVOLT Labs are building a creator empire

Watch full video on YouTube

Why Infiniti is pinning its turnaround hopes on its new SUV

Watch full video on YouTube

ConocoPhillips: More Upside Given Long-Term Cash Flow Tailwinds (NYSE:COP)

This article was written byFollowOver fifteen years of experience making contrarian bets…

LIVE Stock market today: Dow rises, S&P 500 and Nasdaq slip as chip stocks tank, oil surges

Watch full video on YouTube

Perspective: Apple’s crackdown on vibe coding apps

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

News

ConocoPhillips: More Upside Given Long-Term Cash Flow Tailwinds (NYSE:COP)

By News Room
News

MaxCyte, Inc. (MXCT) Q1 2026 Earnings Call Transcript

By News Room
News

Draganfly Inc. (DPRO) Q1 2026 Earnings Call Transcript

By News Room
News

Fidelity Blue Chip Growth Fund Q1 2026 Commentary (FBGRX)

By News Room
News

Ryerson Holding Corporation 2026 Q1 – Results – Earnings Call Presentation (NYSE:RYZ) 2026-05-09

By News Room
News

Gogo Inc. (GOGO) Q1 2026 Earnings Call Transcript

By News Room
News

Magnite, Inc. 2026 Q1 – Results – Earnings Call Presentation (NASDAQ:MGNI) 2026-05-07

By News Room
News

Sound Point Meridian Capital Preferreds: Inadequate Compensation For Embedded Credit Risk

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?